THERAPEUTIC AREA
saveDermatology
Diseases of the skin.
also known as: derm, skin
🐶 often sniffed alongside
top 8- tagRecall56 co-mentions · 33 sources
- tagAdCom44 co-mentions · 30 sources
- drugbenzoyl peroxide27 co-mentions · 7 sources
- tag510(k) Clearance26 co-mentions · 23 sources
- tagPMA Approval18 co-mentions · 7 sources
- druginsulin10 co-mentions · 2 sources
- tagOncology9 co-mentions · 4 sources
- tagInfectious Disease7 co-mentions · 4 sources
drugs
300
catalysts
31
news
513
companies
242
Top drugs
view all →Marketed
CLEOCIN
$PFE · 127 catalysts
Marketedclindamycin hydrochloride
Bacterial Pneumonia
90 catalysts
MarketedNALBUPHINE HYDROCHLORIDE
Pain
84 catalysts
Marketedadalimumab
Intermediate Uveitis
$ABBV · 61 catalysts
MarketedDOXYCYCLINE HYCLATE
$AMRX · 49 catalysts
Marketedmethylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
MarketedEfudex
Basal Cell Carcinoma (Basal Cell Epithelioma)
42 catalysts
MarketedMETHYLPREDNISOLONE ACETATE
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti…
41 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Chinese Academy of Medical Sciences Plastic Surgery Hospital — recombinant type III humanized collagen (Phase II Trial Completion)
recombinant type III humanized collagen
→
Apr 30, 2026
phase 2 completion
Jetema Co Ltd — JTM-102 (Phase II Trial Completion)
JTM-102
→
Apr 30, 2026
phase 2 completion
Nigde Omer Halisdemir University — ozonated oil (Phase II Trial Completion)
ozonated oil
→
Apr 30, 2026
phase 2 completion
Vaidya Yagya Dutt Sharma Ayurvedic P. G. Mahavidhyalaya — ayurvedic medicine (Phase II Trial Completion)
ayurvedic medicine
→
Apr 30, 2026
phase 1 2 completion
Centre International de Développement Pharmaceutique — afamelanotide (Phase I/II Trial Completion)
afamelanotide
→
Apr 30, 2026
phase 1 2 completion
University Hospital Geneva — verteporfin (Phase I/II Trial Completion)
verteporfin
→
Apr 30, 2026
phase 1 initiation
$MRK143.37-0.75%
Merck & Co Inc — MK-6050 (Phase I Trial Initiation)
MK-6050
→
Apr 30, 2026
phase 1 initiation
Jiangsu Vcare PharmaTech Co Ltd — VC-005 (Phase I Trial Initiation)
VC-005
→
Apr 30, 2026
phase 0 trial completion
Foundation for the Promotion of Health and Biomedical Research of Valencia — Aquacel Ag + (Phase 0 Trial Completion)
Aquacel Ag +
→
Apr 30, 2026
phase 0 trial completion
Shanghai Jiao Tong University — insulin (Phase 0 Trial Completion)
insulin
→
Recent news
view all →- AstraZeneca, Calidi, Tempest make significant workforce cutsbiospace · 1d ago
- Aclaris drops TSLP program from pipeline after flunking phase 2 eczema testfiercebiotech · 2d ago
- Deaths, failed trials and other recent setbacks in the autoimmune spacebiospace · 2d ago
- Opinion: New organ donation rules are unfair to familiesstat · 5d ago
- Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophenfda recalls · 6d ago
- AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warningbiopharma dive · 7d ago
- J&J and Protagonist’s Icotyde improves psoriatic arthritis but AbbVie’s Skyrizi likely to reignbiospace · 9d ago
- STAT+: Gene therapy’s long-debated cancer risk materializesstat · 9d ago
Data sources
last refreshed 8h ago
Found something off?
comments(0)
5-min edit window · permanent after that